🇺🇸 FDA
Patent

US 12178861

Stabilized liquid and lyophilized ADAMTS13 formulations

granted A61KA61K38/4886A61K47/02

Quick answer

US patent 12178861 (Stabilized liquid and lyophilized ADAMTS13 formulations) held by Takeda Pharmaceutical Company Limited expires Mon Dec 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Dec 31 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K38/4886, A61K47/02, A61K47/10, A61K47/183